Effects of Tongxinluo on myocardial fibrosis in diabetic rats
Effects of Tongxinluo on myocardial fibrosis in diabetic rats
复制标题
DOI:
10.1016/j.jcma.2015.06.022
复制
发表时间:
2016-03-01
影响因子:
3
通讯作者:
Zhang, Zhimian
中科院分区:
文献类型:
--
作者:
Wang, Xiaomei;Mu, Changzheng;Zhang, Zhimian
Background: The aim of this study was to explore the effect of Tongxinluo on myocardial fibrosis in diabetic rats and its possible mechanism of action.Methods: Diabetic rat models were established and then divided into three groups: control, diabetes, and Tongxinluo groups. Heart function and myocardial interstitial collagen volume fraction were investigated, and the protein and mRNA expression levels of transforming growth factor beta 1 (TGF-beta(1)), Smad(3), and Smad(7) were measured.Results: Heart function was clearly abnormal in the diabetes group compared with that in the control group, and the collagen volume fraction and mRNA expression levels of TGF-beta(1) and Smad(3) were higher. However, the protein and mRNA expression levels of Smad7 were lower. In the Tongxinluo group, it was observed that these indicators were improved.Conclusion: Tongxinluo was effective for the prevention and treatment of myocardial fibrosis in diabetic rats. It probably mediates the expressions of TGF-beta(1), Smad(3), and Smad(7) in rat cardiomyocytes to reduce the occurrence of myocardial fibrosis in diabetic rats. Copyright (C) 2015, the Chinese Medical Association. Published by Elsevier Taiwan LLC.